Search Results for "Tensha Pharmaceuticals"
22:22 EDT 19th May 2013 | BioPortfolio
Original Source: Tensha Therapeutics
Tensha Therapeutics is developing small molecule bromodomain inhibitors, a new class of epigenetic modulators of gene expression, to treat cancer and other serious disorders. The companyâs programs are based on the discovery from the laboratory of Dr. James Bradner at Dana-Farber Cancer Institute of first-in-class, potent small molecule BET bromodomain inhibitors. The companyâs lead program is aimed at the treatment of patients with BRD4-NUT midline...
Matching Channels
None
Matching News
Researchers at Dana-Farber and the Baylor College of Medicine have shown that Tensha's bromodomain inhibitors could prevent sperm production and be developed as a male contraceptive. The biotech, whic...
Matching PubMed Articles
None
Search Whole site using Google
Loading
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
